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Abstract: A new method has been developed for the 
stereoselective construction of the AB rings of the quinolizidine 
skeleton of matrine-type alkaloids with a cis-cis 
stereochemistry. The key features of this method involve: (i) 
the construction of the quinolizidine by the reduction of an 
acylpyridinium cation; and (ii) the late stage introduction of 
methoxypyridine by sequential Stille coupling and 
diastereoselective hydrogenation reactions. 
Keywords: Quinolizidines, stereoselective synthesis, alkaloids, 
matrine, pyridines 
Matrine is representative of the alkaloids derived from 
Sophora flavescens Ait., and has been used for many 
years as a traditional Chinese medicine (KuShen).1 
The structure of matrine is characterized by a 
tetracyclic core consisting of two quinolizidines and 
four contiguous stereogenic centers (Figure 1).2 To 
date, over 30 matrine-type alkaloids have been 
reported in the literature, and these compounds 
usually only differ from each other in terms of their 
oxidation level and relative stereochemistry.3 
Alkaloids belonging to this structural class also 
exhibit a variety of biological properties, including 
antitumor4a,e, anti-viral4b,c, and anti-inflammatory4d 
activities. Because of their interesting and diverse 
biological activities, these compounds have attracted 
considerable attention from medicinal chemists. 
 
Figure 1 Matrine and related quinolizidine alkaloids. 
Although there are many congeners in this structural 
class, only four racemic total syntheses and three 
semi-syntheses have been reported to date, including 
those of matrine6-8,9a, leontine6a, sophoramine9b and 
isosophoramine.9c,10 These syntheses revealed that the 
stereoselective construction of the tetracyclic core of 
these compounds represents a significant synthetic 
challenge. Brown et al.11 recently reported the 
synthesis of (+)-allomatrine, where the tetracyclic 
core was elegantly constructed in a diastereoselective 
manner using an imino-aldol reaction and N-
acyliminium cyclization. Methods for the 
stereoselective synthesis of tetracyclic cores with a 
cis-cis configuration, however, such as those found in 
sophoramine and matrine, remain scarce. We recently 
reported a procedure for the synthesis of 
quinolizidines by the reduction of acylpyridinium 
cations under mild conditions.5 It was envisaged that 
this method could be used as a powerful tool for the 
concise synthesis of quinolizidine alkaloids, because 
the resulting products could be readily derivatized. 
With this in mind, we became interested in 
investigating the application of our method to the 
stereoselective synthesis of the AB rings of matrine 
type alkaloids with cis-cis stereochemistry. 
Retrosynthetically, alcohol 1 was set as a suitable 
synthetic target, because it was envisaged that this 
compound would provide comprehensive access to 
matrine and several related alkaloids via the 
cyclization of the C ring and the adjustment of the 
oxidation levels (Scheme 1). The cis-cis 
stereochemistry of 1 could be successfully installed by 


























































Scheme 1 Retrosynthetic analysis of matrine type alkaloids. 
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could be accessed via the introduction of a C1 unit to 
the quinolizidine core of compound 3, which could be 
constructed via the reduction of the acylpyridinium 
cation derived from carboxylic acid 4 (route a). 
Alternatively, the addition of a pyridyl moiety to 
compound 6, which could be derived from 7, could 
also be used to provide access alcohol 1 (route b). 
Herein, we report the development of a stereoselective 
synthesis of the key cis-cis intermediate 1 based on 
our reductive cyclization strategy by examining both 
possibilities. 
To begin, we examined route a, which required the 
challenging selective reduction of one of two 
pyridines. The synthesis of the cyclization precursor 4 
started with the Stille coupling of 2-iodopicolinate 
methyl ester 812 and pyridylstannane 913 using 
catalytic amounts of Pd(PPh3)4 and CuI (Scheme 2). 
CuI was essential for the production of bipyridine 
10.14 Compound 10 was converted to carboxylic acid 
4 by the Horner-Wadsworth-Emmons reaction of 11 
with ethyl glyoxylate, followed by sequential 
hydrogenation and hydrolysis reactions, which gave 
the cyclization precursor 4 in 50% yield from the 
coupling product 10.15 The quinolizidine skeleton was 
constructed by the reduction of the acylpyridinium 
cation intermediate, which was produced by the 
activation of one of the two pyridine rings of 4. 
Treatment of 4 with Ghosez’s reagent followed by 
Hantzsch ester gave the desired product 3 in 36% 
yield. This low yield was attributed to the unfavorable 
nucleophilic attack of the nitrogen of the other 
pyridine on the in situ generated acid chloride. 
Hydrogenation of the cyclized product 3 proceeded 
stereoselectively to give the desired compound 12 as a  
 
Scheme 2 Synthesis of bipyridine 4 and it's cyclization. (a) 
Pd(PPh3)4, CuI, DMF, 110 °C, 74%; (b) nBuLi, MeP(O)(OMe)2, 
THF, 78 °C; (c) tBuOK, EtO2CCHO, DME, 20 °C, 57% (2 
steps); (d) H2, Pd/C, AcOEt; (e) LiOH, THF-H2O, 88% (2 steps); 
(f) Ghosez's reagent, MS 4Å then Hantzsch ester, ClCH2CH2Cl, 
36%; (g) H2, Pd/C, EtOH, 70%. 
single isomer. The newly generated stereochemistry 
was confirmed by NOE experiments. Whilst ketone 
12 was accessed in stereoselective manner, the 
quinolizidine ring formation resulted in a low yield 
and we decided to then focus our efforts on the other 
route for accessing the cis-cis intermediate 1. 
The second route started from 2-bromo-3-
hydroxymethylpyridine (13)16, which was converted 
to the corresponding benzyl ether 14 using standard 
techniques (Scheme 3). Subsequent treatment of 14 
with n-butyl lithium followed by the addition of 
succinic anhydride 15 gave carboxylic acid 7, albeit in 
low yield (45%). To improve the yield and 
reproducibility of this step, compound 14 was first 
converted to the 2-TMS-pyridine species, which was 
treated with succinic anhydride 15 to give carboxylic 
acid 7 in 65% yield over two steps.15,17 Compound 7 
was then successfully converted to compound 6 by 
treatment with Ghosez’s reagent followed by 
Hantzsch ester.18 Compound 6 was found to be 
unstable, and was immediately hydrogenated over 
Pd/C to give ketone 16, whose stereochemistry was 
confirmed by NOE experiments and the coupling 
constants in its 1H NMR, as shown in Figure 2. The 
second route performed more effectively than the first 
route in terms of the number of steps required and the 
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Scheme 3 Synthesis of quinolizidine 16. (a) BnBr, NaH, DMF, 
68%; (b) nBuLi then succinic anhydride 15, Et2O, 78 °C to RT, 
45%; (c) nBuLi, TMSCl, Et2O, 78 °C to RT; (d) 15, ClCH2CH2Cl, 
100 °C, 65% (two steps); (e) Ghosez's reagent, MS 4Å then 
Hantzsch ester, ClCH2CH2Cl, °C to RT, 61%; (f) H2, Pd/C, 
EtOH, 53%. 
 
Figure 2 1H NMR coupling constant and NOESY experiments of 
compound 16 (left) and a stable conformation calculated by 
Spartan at the B3LYP/6-31+G(d) level of theory (DFT) (right). 
We then proceeded to investigate the stereoselective 
introduction of the pyridyl moiety into compound 16. 
Preliminary studies revealed that the structurally 
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related ketone 12 was readily enolized rather than 
attacked by nucleophiles such as TMSCH2Li and 
Ph3P=CH2.19 The treatment of compound 16 with 
NaHMDS and Comins’ reagent gave enol triflate 17 
together with a significant amount of its regioisomer 
18 in a combined yield of 61% (17:18 = 1.3:1) 
(Scheme 4). A variety of different bases (i.e., LDA, 
LiTMP, TrLi, KHMDS, NaHMDS, LiHMDS, Et3N) 
and triflating reagents (i.e., Tf2O, Tf2NPh, and 
Comins’ reagent20) were evaluated for this 
transformation, but none of these combinations led to 
an improvement in the low regioselectivity. 
Pleasingly, it was possible to separate these two 
compounds by silica gel column chromatography, and 
this allowed for sufficient quantities of the enol triflate 
17 to be obtained for the subsequent Stille coupling. 
Following an extensive investigation of the conditions 
required for the coupling of 17 with 9 using several 
copper salts such as CuTC21, CuBr•SMe2, and 
CuDPP22, it was found that the reaction proceeded 
smoothly in the presence of catalytic Pd(PPh3)4 with 
CuDPP (copper(I) diphenylphosphinate) and LiCl in 
THF at 50 °C to give the coupling product 5 in good 
yield. Hydrogenation of 5 gave compound 19 as a 
single isomer, because the  face was shielded by the 
hydroxymethyl group (Figure 3, left). The newly 
generated stereochemistry was confirmed by NOE 
experiments (Figure 3, right). Finally, reduction with 
LiAlH4 gave the common intermediate 1 with the 
required cis-cis stereochemistry.23 
 
Scheme 4 Synthesis of common intermediate 1. (a) NaHMDS, 
Comins' reagent, THF, 78 to 0 °C, 61%, (17:18 = 1.3:1); (b) 9, 
Pd(PPh3)4, CuDPP, LiCl, THF, 50 °C, 67%; (c) Pd/C, H2 (5 atm), 
EtOH, 70 °C, 65%; (d) LiAlH4, THF, 50 °C, 80%. 
 
Figure 3 Regioselectivity of hydrogenation of compound 5 (left), a 
stable conformation calculated by Spartan at the B3LYP/6-
31+G(d) level of theory (DFT) (middle), NOESY experiments of 
compound 19 (right). 
In summary, we have developed a method for the 
concise synthesis of quinolizidine 1 in a 
stereoselective manner. The key features of this 
method include: (i) the construction of the 
quinolizidine ring by the reduction of an 
acylpyridinium cation; and (ii) the late stage 
introduction of a pyridyl group by sequential Stille 
coupling and hydrogenation reactions. This synthetic 
strategy represents a reasonable technique for the 
stereoselective construction of quinolizidine rings 
with cis-cis stereochemistry. The synthesis of matrine-
type alkaloids such as sophoramine, sophocarpine and 
matrine from quinolizidine 1 via the construction of 
the C ring and subsequent adjustment of the oxidation 
levels is currently underway in our laboratory. 
Supporting Information for this article is available 
online at http://www.thieme-connect.com/ejournals/ 
toc/synlett. 
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